Great Point Partners as of June 30, 2017
Portfolio Holdings for Great Point Partners
Great Point Partners holds 35 positions in its portfolio as reported in the June 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Arena Pharmaceuticals | 7.4 | $41M | 2.4M | 16.87 | |
Ptc Therapeutics I (PTCT) | 7.1 | $40M | 2.2M | 18.33 | |
Adamas Pharmaceuticals | 6.9 | $39M | 2.2M | 17.49 | |
Vanda Pharmaceuticals (VNDA) | 6.5 | $36M | 2.2M | 16.30 | |
Zogenix | 6.3 | $35M | 2.4M | 14.50 | |
Synergy Pharmaceuticals | 5.8 | $32M | 7.2M | 4.45 | |
Concert Pharmaceuticals I equity | 5.0 | $28M | 2.0M | 13.95 | |
Neurocrine Biosciences (NBIX) | 4.9 | $28M | 600k | 46.00 | |
Rigel Pharmaceuticals (RIGL) | 4.5 | $25M | 9.1M | 2.73 | |
Sage Therapeutics (SAGE) | 4.2 | $24M | 295k | 79.64 | |
Foamix Pharmaceuticals | 4.0 | $22M | 4.8M | 4.64 | |
Alnylam Pharmaceuticals (ALNY) | 4.0 | $22M | 277k | 79.76 | |
Selecta Biosciences (RNAC) | 3.3 | $19M | 938k | 19.86 | |
Ignyta | 3.2 | $18M | 1.7M | 10.35 | |
Dbv Technologies S A (DBVT) | 3.2 | $18M | 500k | 35.71 | |
Acceleron Pharma | 2.7 | $15M | 494k | 30.39 | |
Pacira Pharmaceuticals (PCRX) | 2.6 | $14M | 300k | 47.70 | |
Seattle Genetics | 2.3 | $13M | 250k | 51.74 | |
Portola Pharmaceuticals | 2.2 | $12M | 216k | 56.17 | |
Neuroderm Ltd F | 1.7 | $9.3M | 311k | 29.90 | |
Insmed (INSM) | 1.7 | $9.2M | 539k | 17.16 | |
Aimmune Therapeutics | 1.6 | $9.0M | 435k | 20.56 | |
Newlink Genetics Corporation | 1.4 | $8.0M | 1.1M | 7.35 | |
Bovie Medical Corporation | 1.3 | $7.2M | 2.9M | 2.47 | |
Amarin Corporation (AMRN) | 1.3 | $7.1M | 1.8M | 4.03 | |
Global Blood Therapeutics In | 1.2 | $7.0M | 255k | 27.35 | |
Cara Therapeutics (CARA) | 0.9 | $4.9M | 321k | 15.38 | |
Dynavax Technologies (DVAX) | 0.8 | $4.2M | 436k | 9.65 | |
Sunesis Pharmaceuticals Inc Ne | 0.7 | $3.9M | 1.4M | 2.70 | |
Myovant Sciences | 0.5 | $2.9M | 248k | 11.70 | |
Connecture | 0.5 | $2.6M | 4.1M | 0.62 | |
Iovance Biotherapeutics (IOVA) | 0.2 | $1.2M | 169k | 7.35 | |
Aradigm | 0.1 | $835k | 637k | 1.31 | |
Amicus Therapeutics (FOLD) | 0.0 | $125k | 12k | 10.08 | |
Streamline Health Solutions (STRM) | 0.0 | $139k | 130k | 1.07 |